BSE filing, NSE: LINCOLN. Summary written from the filing by ALFA Finder's alert engine.
Lincoln Pharmaceuticals Ltd: key numbers
- Share price
- ₹558.10
- Market cap
- ₹1,118 Cr
- Revenue (annual)
- ₹671.0 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 11.6×Sector 46.1×
- Promoter holding
- 49.78%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lincoln Pharmaceuticals Ltd
All →Lincoln Pharmaceuticals Board Meeting Date
Lincoln Pharmaceuticals intimated that its Board meeting is scheduled for 29 Oct 2026 to approve Q1/H1 2026 financial results. Trading window remains closed until 48 hours after results are published.
Lincoln Pharmaceuticals Other Announcement
Lincoln Pharmaceuticals Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Lincoln Pharmaceuticals Management Change
Lincoln Pharmaceuticals Ltd announced the resignation of Mr. Pradeep Kumar Yadav, Senior General Manager - Quality Assurance, effective October 17, 2026.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals submitted the minutes and voting results of its 32nd Annual General Meeting held on September 30, 2026. The meeting concluded successfully.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals held its 32nd Annual General Meeting on September 30, 2026, where shareholders considered financial statements, dividends, and director reappointments.
Lincoln Pharmaceuticals Other Announcement
Lincoln Pharmaceuticals has dispatched physical letters to shareholders with unregistered email IDs to provide access to the Annual Report for FY 2025-26 and facilitate KYC updates.
Other management change announcements
All →Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
TruCap Finance Management Change
TruCap Finance designated three employees as Senior Management Personnel, effective 29 October 2026. The changes are additional charges for Product, Operations and Contact Centre roles.
Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.